VVT Med Enters Panama Market Through Trial Distribution Agreement

VVT Med Inc. has entered the Panama market through a 12-month Trial Distribution and Evaluation Agreement with local distributor Ebtec, effective October 5, 2026. Ebtec will serve as a conditionally exclusive trial distributor for VVT Med's ScleroSafe platform, focusing on physician education and clinical evaluation. A performance review will take place before the agreement's conclusion, potentially leading to a five-year exclusive distribution contract. This move is part of VVT Med's strategy to enhance its presence in Latin America.